1.Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites.
Raly James Perez CUSTODIO ; Chrislean Jun BOTANAS ; Seong Shoon YOON ; June Bryan DE LA PEÑA ; Irene Joy DELA PEÑA ; Mikyung KIM ; Taeseon WOO ; Joung Wook SEO ; Choon Gon JANG ; Yong Ho KWON ; Nam Yong KIM ; Yong Sup LEE ; Hee Jin KIM ; Jae Hoon CHEONG
Biomolecules & Therapeutics 2017;25(6):578-585
Recently, there has been a rise in the number of amphetamine derivatives that serve as substitutes for controlled substances (e.g. amphetamine and methamphetamine) on the global illegal drug market. These substances are capable of producing rewarding effects similar to their parent drug. In anticipation of the future rise of new and similar psychoactive substances, we designed and synthesized four novel amphetamine derivatives with N-benzyl, N-benzylamphetamine HCl (NBNA) substituent on the amine region, 1,4-dioxane ring, ethylenedioxy-amphetamine HCl (EDA), methyl, para-methylamphetamine HCl (PMEA), and naphthalene, 2-(aminopropyl) naphthalene HCl (2-APN) substituents on the phenyl site. Then, we evaluated their abuse potential in the conditioned place preference (CPP) test in mice and self-administration (SA) test in rats. We also investigated the psychostimulant properties of the novel drugs using the locomotor sensitization test in mice. Moreover, we performed qRT-PCR analyses to explore the effects of the novel drugs on the expression of D1 and D2 dopamine receptor genes in the striatum. NBNA, but not EDA, PMEA, and 2-APN, induced CPP and SA in rodents. None of the test drugs have produced locomotor sensitization. qRT-PCR analyses demonstrated that NBNA increased the expression of striatal D1 dopamine receptor genes. These data indicate that NBNA yields rewarding effects, suggesting potential for abuse. Continual observation for the rise of related substances is thus strongly encouraged.
Amphetamine*
;
Animals
;
Controlled Substances
;
Humans
;
Mice
;
Parents
;
Rats
;
Receptors, Dopamine
;
Reward
;
Rodentia
2.Diagnosis and Treatment of Inflammatory Joint Disease.
Yeesuk KIM ; Hyun Cheol OH ; Jang Won PARK ; In Sung KIM ; Jun Young KIM ; Ki Choul KIM ; Dong Sik CHAE ; Woo Lam JO ; Joo Hyoun SONG
Hip & Pelvis 2017;29(4):211-222
Arthritis damages the cartilage within joints, resulting in degenerative changes, including loss of function and joint instability. Ankylosing spondylitis (AS) is a chronic inflammatory condition affecting the spine and bone-to-tendon attachment area within the sacroiliac joint leading to back pain and progressive spinal stiffness. In the final stages, AS causes hyperkyphosis-a condition closely tied to the human leukocyte antigen-B27 gene. Rheumatoid arthritis is a chronic, systemic autoimmune disease characterized by the simultaneous inflammation of the synovium of multiple joints, leading to joint damage (e.g., destruction, deformation and disability). In the past, nonsteroidal anti-inflammatory drugs or conventional disease-modifying antirheumatic drug (DMARDs) have been used for the treatment of these autoimmune diseases, but biologic DMARDs have recently been introduced with excellent results. Gout is a chronic inflammatory disease that causes an alteration of joints resulting in severe pain. Specifically, gout is associated with an accumulation of uric acid within the body resulting from dysregulated purine metabolism, causing recurrent paroxysmal inflammation in the joints. Allopurinol and febuxostat are the primary treatment options for individuals with gout. It is necessary to have an accurate understanding of the pathogenesis, pathological ecology and treatment of AS, rheumatoid arthritis, and gouty arthritis, which are the representative diseases that may cause inflammatory arthritis.
Allopurinol
;
Antirheumatic Agents
;
Arthritis
;
Arthritis, Gouty
;
Arthritis, Reactive
;
Arthritis, Rheumatoid
;
Autoimmune Diseases
;
Back Pain
;
Cartilage
;
Diagnosis*
;
Ecology
;
Febuxostat
;
Gout
;
Humans
;
Inflammation
;
Joint Diseases*
;
Joint Instability
;
Joints*
;
Leukocytes
;
Metabolism
;
Sacroiliac Joint
;
Spine
;
Spondylitis, Ankylosing
;
Synovial Membrane
;
Uric Acid
3.Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
Minha HONG ; Seung Yup LEE ; Juhee HAN ; Jin Cheol PARK ; Yeon Jung LEE ; Ram HWANGBO ; Hyejung CHANG ; Seong Woo CHO ; Soo Young BHANG ; Bongseog KIM ; Jun Won HWANG ; Geon Ho BAHN
Journal of Korean Medical Science 2017;32(10):1687-1693
Children with autism are often medicated to manage emotional and behavioral symptoms; yet, data on such pharmacotherapy is insufficient. In this study, we investigated the Korean National Health Insurance Claims Database (NHICD) information related to autism incidence and psychotropic medication use. From the 2010–2012 NHICD, we selected a total of 31,919,732 subjects under 19 years old. To examine the diagnostic incidence, we selected patients who had at least one medical claim containing an 10th revision of International Statistical Classification of Diseases and Related Health Problems (ICD-10) code for pervasive developmental disorder, F84, not diagnosed in the previous 360 days. Psychotropics were categorized into seven classes. Then, we analyzed the data to determine the mean annual diagnostic incidence and psychotropic prescription trends. Diagnostic incidence was 17,606 for the 3 years, with a mean annual incidence per 10,000 population of 5.52. Among them, 5,348 patients were prescribed psychotropics. Atypical antipsychotics were the most commonly used, followed by antidepressants. An older age, male sex, and the availability of medical aid were associated with a higher rate of prescription than observed for a younger age, female sex, and the availability of health insurance. Psychotropic drugs were used for less than one-third of patients newly diagnosed with autism, and prescription differed by sex and age. Increased diagnostic incidence is associated with an increased prescription of psychotropic drugs. Therefore, medication-related safety data and policies for psychotropic drugs in autism should be prepared.
Adolescent*
;
Antidepressive Agents
;
Antipsychotic Agents
;
Autistic Disorder*
;
Behavioral Symptoms
;
Central Nervous System Stimulants
;
Child*
;
Drug Therapy
;
Drug Utilization
;
Female
;
Humans
;
Incidence
;
Insurance, Health*
;
International Classification of Diseases
;
Male
;
National Health Programs
;
Prescriptions*
;
Psychotropic Drugs
4.Efficacy of Intensive Neurodevelopmental Treatment for Children With Developmental Delay, With or Without Cerebral Palsy.
Kyoung Hwan LEE ; Jin Woo PARK ; Ho Jun LEE ; Ki Yeun NAM ; Tae June PARK ; Hee Jae KIM ; Bum Sun KWON
Annals of Rehabilitation Medicine 2017;41(1):90-96
OBJECTIVE: To evaluate the effectiveness of intensive neurodevelopmental treatment (NDT) on gross motor function for the children having developmental delay (DD), with or without cerebral palsy (CP). METHODS: Forty-two children had intensive NDT three times weekly, 60 minutes a day, for 3 months, immediately followed by conventional NDT once or twice a week, 30 minutes a day, for another 3 months. We assessed Gross Motor Function Measure (GMFM) over three time points: before conventional NDT, before and after intensive NDT, and after 3 months of additional conventional NDT. RESULTS: The GMFM score in DD children significantly improved after intensive NDT, and the improvement maintained after 3 months of conventional NDT (p<0.05). The children were further divided into two groups: DD with CP and DD without CP. Both groups showed significant improvement and maintained the improvements, after intensive NDT (p<0.05). Also, there was no significant difference in treatment efficacy between the two groups. When we calculate the absence rate for comparing the compliance between intensive and conventional NDT, the absence rate was lower during the intensive NDT. CONCLUSION: Intensive NDT showed significantly improved gross motor function and higher compliance than conventional NDT. Additionally, all improvements were maintained through subsequent short-term conventional NDT. Thus, we recommend the intensive NDT program by day-hospital centers for children with DD, irrespective of accompanying CP.
Cerebral Palsy*
;
Child*
;
Compliance
;
Developmental Disabilities
;
Disability Evaluation
;
Humans
;
Rehabilitation
;
Treatment Outcome
5.Comparison of Surgical Outcomes Between Holmium Laser Enucleation and Transurethral Resection of the Prostate in Patients With Detrusor Underactivity.
Myeong Jin WOO ; Yun Sok HA ; Jun Nyung LEE ; Bum Soo KIM ; Hyun Tae KIM ; Tae Hwan KIM ; Eun Sang YOO
International Neurourology Journal 2017;21(1):46-52
PURPOSE: Currently, holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TURP) are the standard surgical procedures used to treat benign prostatic hyperplasia (BPH). Several recent studies have demonstrated that the surgical management of BPH in patients with detrusor underactivity (DU) can effectively improve voiding symptoms, but comparative data on the efficacy of HoLEP and TURP are insufficient. Therefore, we compared the short-term surgical outcomes of HoLEP and TURP in patients with DU. METHODS: From January 2010 to May 2015, 352 patients underwent HoLEP or TURP in procedures performed by a single surgeon. Of these patients, 56 patients with both BPH and DU were enrolled in this study (HoLEP, n=24; TURP, n=32). Surgical outcomes were retrospectively compared between the 2 groups. DU was defined as a detrusor pressure at maximal flow rate of <40 cm H(2)O as measured by a pressure flow study. RESULTS: The preoperative characteristics of patients and the presence of comorbidities were comparable between the 2 groups. The TURP group showed a significantly shorter operative time than the HoLEP group (P=0.033). The weight of the resected prostate was greater in the HoLEP group, and postoperative voiding parameters, including peak flow rate and postvoid residual urine volume were significantly better in the HoLEP group than in the TURP group. CONCLUSIONS: HoLEP can be effectively and safely performed in patients with DU and can be expected to have better surgical outcomes than TURP in terms of the improvement in lower urinary tract symptoms.
Comorbidity
;
Holmium*
;
Humans
;
Lasers, Solid-State*
;
Lower Urinary Tract Symptoms
;
Operative Time
;
Prostate*
;
Prostatic Hyperplasia
;
Retrospective Studies
;
Transurethral Resection of Prostate
6.The effect of pre-anesthetic administration of dexmedetomidine on the consumption of opioids in postoperative gynecologic patients.
Kang Yoo LEE ; Woo Yong LEE ; Kye Min KIM ; Byung Hoon YOO ; Sangseok LEE ; Yun Hee LIM ; Mun Cheol KIM ; Jun Heum YON
Anesthesia and Pain Medicine 2017;12(1):37-41
BACKGROUND: This study was designed to assess whether pre-anesthetic administration of dexmedetomidine reduces the postoperative consumption of opioids, in patients receiving patient-controlled fentanyl after gynecological laparotomy. METHODS: This was a prospective, randomized, double-blind, controlled study. Ten minutes before induction of anesthesia, 36 patients scheduled for elective gynecological laparotomy were assigned to receive either normal saline (group N) or dexmedetomidine 1 µg/kg (group D). A patient-controlled analgesia (PCA) device was used to administer fentanyl for the postoperative 24 h period. Cumulative fentanyl consumption and pain score were assessed at postoperative 30 min, 6 h and 24 h. Patient's satisfaction for pain control and other side effects (nausea, sedation score) were recorded for all corresponding time points. RESULTS: There was no significant difference between the groups in cumulative fentanyl consumption (Group N: 11.1 ± 3.2 µg/kg, Group D: 10.3 ± 2.9 µg/kg, P value: 0.706). The incidence of side-effects did not differ between the groups. Both groups showed similar blood pressure after anesthesia induction. However, 10 min after anesthesia induction, the heart rates in group D were significantly lower than group N (P = 0.0002). CONCLUSIONS: In patients undergoing gynecological laparotomy, the pre-anesthetic administration of single loading dose dexmedetomidine (1 µg/kg) given 10 min before anesthesia induction did not reduce the PCA consumption of postoperative fentanyl or the pain score.
Adrenergic alpha-2 Receptor Agonists
;
Analgesia, Patient-Controlled
;
Analgesics, Opioid*
;
Anesthesia
;
Blood Pressure
;
Dexmedetomidine*
;
Fentanyl
;
Heart Rate
;
Humans
;
Incidence
;
Laparotomy
;
Pain, Postoperative
;
Passive Cutaneous Anaphylaxis
;
Prospective Studies
7.Comparison of commonly used ICR stocks and the characterization of Korl:ICR.
Hye Jun SHIN ; Young Min CHO ; Hee Jung SHIN ; Hae Deun KIM ; Kyung Min CHOI ; Mi Gyeong KIM ; Hyoung Doo SHIN ; Myeon Woo CHUNG
Laboratory Animal Research 2017;33(1):8-14
Mouse is a commonly used animal in life science studies and is classified as outbred if genetically diverse and inbred if genetically homogeneous. Outbred mouse stocks, are used in toxicology, oncology, infection and pharmacology research. The National Institute of Food and Drug Safety Evaluation (NIFDS; former the Korea National Institute of Health) have bred ICR mice for more than 50 years. We investigated to provide users with information and promote accountability to the Korl:ICR. To secure the indigenous data, biological characteristics of Korl:ICR were identified by comparing with other ICR stocks. This domestic ICR stock was denominated as ‘Korl:ICR’. Phylogenetic analysis using SNPs indicated that the population stratification of the Korl:ICR was allocated different area with other ICR. In addition, we measured litter size, body weight, body length, various organ weight, hematology and clinical blood chemistry of the Korl:ICR compared to other ICR. Otherwise, there are no significant differences among the biological phenotypes of Korl:ICR and other ICR. These results suggest that as a genetically indigenous source colony, the Korl:ICR is seperated (or independent) stock with other ICR. Also, we confirmed that there is no difference among the Korl:ICR and other ICR on biological phenotypes. Therefore, the Korl:ICR source colony might be a new stock in distinction from other ICR, it is a good milestone in securing ownership of the national laboratory animal resource. The NIFDS expects that the Korl:ICR mice will be useful animal resource for our domestic researchers.
Animals
;
Animals, Laboratory
;
Biological Science Disciplines
;
Body Weight
;
Chemistry
;
Hematology
;
Korea
;
Litter Size
;
Mice
;
Mice, Inbred ICR
;
Organ Size
;
Ownership
;
Pharmacology
;
Phenotype
;
Polymorphism, Single Nucleotide
;
Population Characteristics
;
Rodentia
;
Social Responsibility
;
Toxicology
8.Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases.
Young Jun WOO ; Chang Yeom KIM ; Bradford SGRIGNOLI ; Jin Sook YOON
Korean Journal of Ophthalmology 2017;31(3):194-201
PURPOSE: To report the patient characteristics and treatment outcomes in 12 cases of orbital lymphangioma. METHODS: In this study, orbital lymphangioma was diagnosed based on clinical, radiologic (computed tomography, magnetic resonance imaging), and histologic findings when possible. Patients whose vision was not compromised by orbital lymphangioma, or that did not have increased intraocular pressure (IOP), received oral corticosteroids. Orbital lymphangioma that affected vision or increased IOP was treated by surgery, which included aspiration of blood or partial resection with or without injection of a sclerosant. RESULTS: Four patients without compromised vision responded well to oral corticosteroids. Eight patients with compromised vision underwent some form of surgery. Bleeding recurred in three patients after aspiration of blood and in two after partial resection and intralesional injection of a sclerosant. Overall, five patients were treated successfully by aspiration of blood, intralesional injection of a sclerosant, and application of continuous negative pressure by appropriate drainage. Partial resection was successful in two patients with organized hematoma. CONCLUSIONS: Orbital lymphangioma that does not compromise vision can be treated medically using oral corticosteroids. Patients with threatened vision or elevated IOP due to acute hemorrhage should be treated by aspiration of blood, intralesional injection of a sclerosant, and application of continuous negative pressure. Partial resection may be effective only in patients with organized hematoma.
Adrenal Cortex Hormones
;
Drainage
;
Hematoma
;
Hemorrhage
;
Humans
;
Injections, Intralesional
;
Intraocular Pressure
;
Lymphangioma*
;
Orbit*
;
Sclerotherapy
;
Treatment Outcome
9.A Case of Androgenetic Alopecia in an Adolescent Female with Response to Topical Minoxidil.
Young Jun WOO ; Yoon Seob KIM ; Jung Eun KIM ; Hoon KANG
Korean Journal of Dermatology 2017;55(1):52-55
Androgenetic alopecia (AGA) is a common form of hair loss that usually occurs in the third or fourth decades of life in men, with later onset in women. AGA does rarely occur, however, in the pediatric population. Adolescent AGA is pattern hair loss occurring in boys and girls between 12 and 18 years of age. We herein report the case of a 16-year-old girl with a 5-year history of diffuse hair loss on the crown. Her father had a history of AGA, and the hair pull test was negative. Sex hormone levels and thyroid function test were within the normal range. Phototrichogram analysis revealed diffuse hair thinning over the frontal and vertex areas, and the percentage of vellus hair was higher on the vertex than the occiput. We diagnosed the patient with adolescent AGA. She was prescribed 3% topical minoxidil, and improvement was visible on the clinical photograph and phototrichogram after 2 years of treatment.
Adolescent*
;
Alopecia*
;
Crowns
;
Fathers
;
Female*
;
Hair
;
Humans
;
Male
;
Minoxidil*
;
Reference Values
;
Thyroid Function Tests
10.A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index.
Ho Jin KIM ; Jun Sung MOON ; Il Rae PARK ; Joong Hee KIM ; Ji Sung YOON ; Kyu Chang WON ; Hyoung Woo LEE
Endocrinology and Metabolism 2017;32(3):375-382
BACKGROUND: Plasma soluble cluster determinant 36 (sCD36) level is closely related with insulin resistance and atherosclerosis, but little is known whether it could be a surrogate for estimating risk of developing diabetes or not. To address this, we evaluated association between sCD36 index, the product of sCD36 and fasting plasma glucose (FPG), and the prevalence of type 2 diabetes mellitus (T2DM), and then compared with triglyceride-glucose (TyG) index which has been suggested simple index for insulin resistance. METHODS: This was cross-sectional study, and participants were classified as normal glucose tolerance (NGT), prediabetes, and T2DM according to glucose tolerance. The formula of TyG index was ‘ln [FPG (mg/dL)×triglyceride (mg/dL)/2],’ and the sCD36 index was ‘ln [sCD36 (pg/mL)×FPG (mg/dL)/2].’ RESULTS: One hundred and fifty-five subjects (mean age, 55.2 years) were enrolled, and patients with T2DM were 75. Both indexes were significantly increased in prediabetes and T2DM rather than NGT, and sCD36 index was positively correlated with both glycosylated hemoglobin and homeostasis model assessment of insulin resistance (r=0.767 and r=0.453, respectively; P<0.05) and negatively with homeostasis model assessment estimate of β-cell function (r=−0.317). The odds ratio (OR) of sCD36 index for T2DM was 4.39 (95% confidential interval, 1.51 to 12.77) after adjusting age, gender, blood pressure, smoking, alcohol, non-high density lipoprotein cholesterol and high-sensitivity C-reactive protein. However, OR of TyG index did not remained significance after adjustment. CONCLUSION: sCD36 index has an independent association with the risk of T2DM, and showed better correlation than TyG index. These results suggest sCD36 index might be useful surrogate marker for the risk of diabetes.
Atherosclerosis
;
Biomarkers
;
Blood Glucose
;
Blood Pressure
;
C-Reactive Protein
;
Cholesterol
;
Cross-Sectional Studies
;
Diabetes Mellitus, Type 2*
;
Fasting
;
Glucose
;
Hemoglobin A, Glycosylated
;
Homeostasis
;
Humans
;
Insulin Resistance
;
Lipoproteins
;
Odds Ratio
;
Plasma
;
Prediabetic State
;
Prevalence*
;
Smoke
;
Smoking

Result Analysis
Print
Save
E-mail